DLD Asset Management’s Akcea Therapeutics Inc AKCA Stock Holding History

DLD Asset Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-206,864	Closed	-$3.75M	–	117
2020 Q3	$3.75M	Buy	+206,864	New	+$2.93M	0.09%	51

DLD Asset Management's AKCA Position: Q4 2020 in Review

DLD Asset Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 206,864 shares — an estimated $3.75M sold.

DLD Asset Management first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $3.75M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

DLD Asset Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
DLD Asset Management sold 206,864 Akcea Therapeutics Inc shares in Q4 2020, an estimated $3.75M.
DLD Asset Management first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
DLD Asset Management's Akcea Therapeutics Inc position peaked at $3.75M in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on DLD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.